Home > Healthcare > Medical Devices > Diagnostic Devices > fecal occult testing market
Get a free sample of Fecal Occult Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Fecal Occult Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Some of the eminent market participants operating in the fecal occult testing market include
These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
The guaiac FOB stool test segment garnered USD 381.3 million in the fecal occult testing industry in 2022 on account of its established reputation in medical practice and historical integration into colorectal cancer screening programs.
Fecal occult testing industry size reached USD 1 billion in 2022 and will witness 7.3% CAGR through 2032 due to the rising incidence of rectal and colon cancer worldwide.
U.S. fecal occult testing industry crossed USD 353.1 million in 2022 and is projected to expand significantly through 2032 owing to the highly advanced and well-established healthcare infrastructure in the region.
HUMASIS.COM, CTK Biotech, Inc., Biopanda Reagents Ltd, Biohit Oyj, CERTEST BIOTEC, Cenogenics Corporation, Alfa Scientific Designs, Inc., Siemens Healthcare GmbH, Jant Pharmacal Corporation., Quidel Corporation, and Wondfo are some of the fecal occult testing companies worldwide.